Whats the Mathematics?

Curing Blindness with Brad Doerschuk

Jeffery W. McGruder II Season 6 Episode 1

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 47:40

Send us Fan Mail

In our first episode of What’s the Mathematics, we sit down with Brad Doerschuk, CEO of InFocus Clinical Research, a global clinical research organization at the forefront of advancing treatments for retinal diseases and vision loss.

Brad breaks down the real-world “math” behind clinical research—from how therapies move through the pharmaceutical pipeline to the global coordination required between biotech companies, physicians, and patients. We dive into the high-stakes world of ophthalmology trials, where innovations like gene therapy and advanced drug delivery systems are pushing the boundaries of what’s possible—including the potential to slow, restore, or even cure blindness. 

This episode explores how specialized firms like InFocus play a critical role in bringing life-changing treatments to market—managing everything from clinical trial design and patient recruitment to regulatory strategy and global execution. 

If you’ve ever wondered how medicine, business, and innovation intersect on a global scale, this conversation gives you a front-row seat to the mathematics behind it all.

Podcasts we love

Check out these other fine podcasts recommended by us, not an algorithm.

Pivot Artwork

Pivot

New York Magazine
The Prof G Pod with Scott Galloway Artwork

The Prof G Pod with Scott Galloway

Vox Media Podcast Network
The Breakfast Club Artwork

The Breakfast Club

The Black Effect Podcast Network and iHeartPodcasts